Skip to main content
. 2020 Dec 8;2020(12):MR000040. doi: 10.1002/14651858.MR000040.pub3

7.5. Analysis.

7.5

Comparison 7: Sensitivity analyses for clinical guidelines, Outcome 5: Re‐categorising financial conflicts of interest into financial conflicts of interest related to the manufacturer